Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014. Boston Globe via Getty Images hide caption

toggle caption Boston Globe via Getty Images

Controversy Continues Over Muscular Dystrophy Drug, Despite FDA Approval

  • Download
  • <iframe src="https://www.npr.org/player/embed/495174472/495295191" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Maria Fabrizio for NPR

Researchers Question Safety, Value Of Untested Stem Cell Treatments

  • Download
  • <iframe src="https://www.npr.org/player/embed/491372940/492674855" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Where are the generic alternatives to EpiPen and other expensive drugs that have lost patent protection? Victor J. Blue/Bloomberg via Getty Images hide caption

toggle caption Victor J. Blue/Bloomberg via Getty Images

The FDA says that facilities that collect blood donations throughout the United States should be testing donations for Zika within 12 weeks. Toby Talbot/AP hide caption

toggle caption Toby Talbot/AP

All U.S. Blood Donations Should Be Screened For Zika, FDA Says

  • Download
  • <iframe src="https://www.npr.org/player/embed/491484838/491531894" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Containers hold genetically modified Aedes aegypti mosquitoes before being released in Panama City, Panama, in September 2014. Arnulfo Franco/AP hide caption

toggle caption Arnulfo Franco/AP

Florida Keys Opposition Stalls Tests Of Genetically Altered Mosquitoes

  • Download
  • <iframe src="https://www.npr.org/player/embed/490313999/490314000" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. Sebastien Bozon/AFP/Getty Images hide caption

toggle caption Sebastien Bozon/AFP/Getty Images

An ad from the Food and Drug Administration's Fresh Empire campaign. FDA hide caption

toggle caption FDA

Notorious FDA? Feds Turn To Hip-Hop To Tamp Down Teen Smoking

  • Download
  • <iframe src="https://www.npr.org/player/embed/476900196/477301535" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Bottles of the abortion-inducing drug RU-486, which is used to medically induce abortions in a two-step process. Women take mifepristone (left), and days later, they take misoprostol. Charlie Neibergall/AP hide caption

toggle caption Charlie Neibergall/AP
Nelson Almeida/AFP/Getty Images

U.S. Health Agencies Intensify Fight Against Zika Virus

  • Download
  • <iframe src="https://www.npr.org/player/embed/464686993/465748345" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Bull's Eye/Imagezoo/Getty Images

FDA Approval Could Turn A Free Drug For A Rare Disease Pricey

  • Download
  • <iframe src="https://www.npr.org/player/embed/460719043/460784659" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Cattle graze in a field near Sacramento, Calif. California Gov. Jerry Brown, along with many health advocacy groups, has called the overuse of antibiotics "an urgent public health problem." Rich Pedroncelli/AP hide caption

toggle caption Rich Pedroncelli/AP